Conversion surgery for gastric cancer patients: A review

Gastric cancer (GC) is the third most common cancer-related cause of death worldwide. In locally advanced tumors, neoadjuvant chemotherapy has recently been introduced in most international Western guidelines. For metastatic and unresectable disease, there is still debate regarding correct management and the role of surgery. The standard approach for stage IV GC is palliative chemotherapy. Over the last decade, an increasing number of M1 patients who responded to palliative regimens of induction chemotherapy have been subsequently undergone surgery with curative intent. The objective of the present review is to analyze the literature regarding this approach, known as “conversion surgery”, which has become one of the most commonly adopted therapeutic options. It is defined as a treatment aiming at an R0 resection after chemotherapy in initially unresectable tumors. The 13 retrospective studies analyzed, with a total of 411 patients treated with conversion therapy, clearly show that even if standardization of unresectable and metastatic criteria, post-chemotherapy resectability evaluation and timing of surgery has not yet been established, an R0 surgery after induction chemotherapy with partial or complete response seems to offer superior survival results than chemotherapy alone. Additional larger sample-size randomized control trials are needed to identify subgroups of well-stratified patients who could benefit from this multimodal approach.     

Meeting abstracts

Abstracts

Meeting abstracts     

Dyspnea during exercise in hyperbaric conditions

INTRODUCTION: Length-tension and force-velocity characteristics of respiratory muscles and hyperinflation are the likely determinants of dyspnea in subjects exercising under hyperbaric conditions. We hypothesize that hyperinflation plays a minor role and that the reduced velocity of shortening of the respiratory muscles modulates dyspnea for any given pleural pressure. METHODS: We studied five normal subjects who performed an incremental exercise test on a cycloergometer in both normobaric (SL) and hyperbaric (4 ATA) conditions. We measured breathing pattern, inspiratory pleural pressure swing (Pessw), Delta Pes (i.e., the difference between the most and the less negative pleural pressures during tidal breathing), and dyspnea intensity (Borg score). End-expiratory lung volume (EELV) changes were evaluated by measuring changes in inspiratory capacity. Mean inspiratory flow (VT/TI) was used as an index of velocity of shortening of respiratory muscles. RESULTS: Compared with SL, at 4 ATA, peak exercise ventilation (VE) (84.5 vs 62.2 L x min(-1)) and VT/TI (2.99 vs 2.16 L x s)(-1) were lower, Pessw (30.9 vs 38.6 cm H2O) and Delta Pes (43.8 vs 62.2 cm H2O) were higher, and Borg score was not different (7.60 vs 8.20 au). EELV decreased progressively during exercise but remained higher than at SL. Borg score was greater for a same VE and lower for a same Delta Pes. VT/TI was lower for a same Pessw. The differences in EELV between SL and 4 ATA did not relate with the concurrent changes in Borg score. CONCLUSION: The results confirm our hypothesis that during exercise in hyperbaric conditions, decreased velocity of shortening of respiratory muscles modulates pressure-induced increases in dyspnea, with hyperinflation playing a minor role.